Repare Therapeutics Inc. (RPTX) Tops Q2 EPS by 17c
Tweet
Share
E-mailGet Alerts RPTX Hot Sheet
Join SI Premium – FREE
Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q2 EPS of ($0.39), $0.17 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $250 thousand versus the consensus estimate of $2.5 million.
For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
